MA21169A1 - Acides desoxyribonucleiques et procede de preparation des proteines qui en derivant. - Google Patents
Acides desoxyribonucleiques et procede de preparation des proteines qui en derivant.Info
- Publication number
- MA21169A1 MA21169A1 MA21406A MA21406A MA21169A1 MA 21169 A1 MA21169 A1 MA 21169A1 MA 21406 A MA21406 A MA 21406A MA 21406 A MA21406 A MA 21406A MA 21169 A1 MA21169 A1 MA 21169A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- derived therefrom
- proteins derived
- deoxyribonucleic acids
- deoxyribonucleic
- Prior art date
Links
- 102000053602 DNA Human genes 0.000 title 1
- 108020004414 DNA Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US932587A | 1987-01-30 | 1987-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA21169A1 true MA21169A1 (fr) | 1988-10-01 |
Family
ID=21736956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA21406A MA21169A1 (fr) | 1987-01-30 | 1988-01-29 | Acides desoxyribonucleiques et procede de preparation des proteines qui en derivant. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0278940A3 (fr) |
JP (1) | JPS6463382A (fr) |
KR (1) | KR880009130A (fr) |
CN (1) | CN1031395A (fr) |
AP (1) | AP56A (fr) |
AU (1) | AU1093088A (fr) |
DD (3) | DD285612A5 (fr) |
DK (1) | DK43188A (fr) |
FI (1) | FI880428A (fr) |
HU (1) | HUT50876A (fr) |
IL (1) | IL85216A0 (fr) |
MA (1) | MA21169A1 (fr) |
NO (1) | NO880395L (fr) |
NZ (1) | NZ223297A (fr) |
OA (1) | OA08801A (fr) |
PT (1) | PT86640B (fr) |
SU (1) | SU1746887A3 (fr) |
TN (1) | TNSN88004A1 (fr) |
YU (1) | YU17488A (fr) |
ZA (1) | ZA88488B (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0299242A3 (fr) * | 1987-06-22 | 1989-01-25 | Medico Labs Ag | Particules immunogènes peptiques virales hétérologues |
NZ228774A (en) * | 1988-04-25 | 1991-05-28 | Phillips Petroleum Co | Hbv particles containing pres 2 proteins and recombinant processes for their production in yeast cells |
EP0345792A3 (fr) * | 1988-06-10 | 1991-05-02 | F. Hoffmann-La Roche Ag | Protéines fusionnées HTLV-I/HIV-I |
FR2635532B1 (fr) * | 1988-07-29 | 1992-05-22 | Pasteur Institut | Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant |
CA2025481A1 (fr) * | 1989-09-19 | 1991-03-20 | Peter J. Kniskern | Vaccin contre le sida et l'hepatite b |
US5130248A (en) * | 1989-09-19 | 1992-07-14 | Merck & Co., Inc. | Expression of fusion protein of HIV envelope and HBsAg |
US5130247A (en) * | 1989-09-19 | 1992-07-14 | Merck & Co., Inc. | Expression of fusion protein of HIV envelope and HBsAG |
EP0491077A1 (fr) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | Composition utilisée comme agent thérapeutique contre des maladies hépatiques chroniques |
ATE177755T1 (de) * | 1991-11-16 | 1999-04-15 | Smithkline Beecham Biolog | Hybrides protein zwischen cs aus plasmodium und hbsag |
ATE199158T1 (de) * | 1991-12-23 | 2001-02-15 | Bayer Ag | Hbv amplifizierungssonden zur verwendung in hybridisierungssandwichassay in der lösungsphase |
US6297048B1 (en) | 1992-02-04 | 2001-10-02 | Chiron Corporation | Hepatitis therapeutics |
US6169171B1 (en) | 1992-02-27 | 2001-01-02 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBSAG |
US5928902A (en) * | 1992-02-27 | 1999-07-27 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBsAg |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
ES2133392T5 (es) * | 1992-03-06 | 2004-12-16 | N.V. Innogenetics S.A. | Procedimiento para la determinacion de peptidos que correspondan a epitopos hcv importantes desde el punto de vista inmunologico. |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
AU2462392A (en) * | 1992-04-14 | 1993-11-18 | British Biotech Pharmaceuticals Limited | Induction of CTL responses |
ES2334181T3 (es) | 1992-05-23 | 2010-03-05 | Glaxosmithkline Biologicals S.A. | Vacunas combinadas que comprenden antigeno de superficie de la hepatitis b y otros antigenos. |
CN1063343C (zh) * | 1993-04-27 | 2001-03-21 | 中国科学院上海生物化学研究所 | 氨端带前表面抗原决定簇的乙型肝炎表面抗原蛋白 |
US6235888B1 (en) | 1994-10-05 | 2001-05-22 | The General Hospital Corporation | Hepatitis C virus vaccine |
RU2189254C2 (ru) * | 1995-06-06 | 2002-09-20 | Америкэн Хоум Продактс Корпорэйшн | Вакцины против вирусов гепатита |
ES2301178T3 (es) | 1996-04-05 | 2008-06-16 | Novartis Vaccines & Diagnostic | Vectores basados en alfavirus recombinantes con inhibicion reducida de la sintesis macromolecular celular. |
CA2266656A1 (fr) | 1996-09-17 | 1998-03-26 | Chiron Corporation | Compositions et procedes de traitement de maladies intracellulaires |
GB9623233D0 (en) | 1996-11-07 | 1997-01-08 | Smithkline Beecham Biolog | Vaccine composition |
PL201482B1 (pl) | 1998-10-16 | 2009-04-30 | Smithkline Beecham Biolog | Sposoby wytwarzania kompozycji szczepionki oraz kompozycja szczepionki |
UA79735C2 (uk) * | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
CN100381171C (zh) * | 2004-12-30 | 2008-04-16 | 成都生物制品研究所 | 含前s1、前s2和s抗原决定簇的乙肝表面抗原复合颗粒 |
CN102675430B (zh) * | 2005-08-12 | 2014-08-27 | 上海贺普药业股份有限公司 | 乙型肝炎病毒表面l蛋白相关肽 |
EP2397853B1 (fr) | 2006-03-14 | 2014-01-15 | Oregon Health and Science University | Procédés pour détecter une infection de tuberculose à mycobactérie |
PL2097102T3 (pl) | 2006-09-07 | 2012-10-31 | Glaxosmithkline Biologicals Sa | Szczepionka skojarzona o zmniejszonej ilości antygenu wirusa polio |
KR100836745B1 (ko) * | 2007-01-31 | 2008-06-10 | (주)두비엘 | Hbv 백신 및 그의 제조 방법 |
WO2008106551A2 (fr) | 2007-02-28 | 2008-09-04 | The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Serv. | Polypeptides brachyury et procédés d'utilisation. |
AU2008248640A1 (en) | 2007-05-02 | 2008-11-13 | Glaxosmithkline Biologicals S.A. | Vaccine |
CA2826508C (fr) | 2008-05-23 | 2016-07-19 | The Regents Of The University Of Michigan | Vaccins a nanoemulsion |
US8664183B2 (en) | 2009-02-27 | 2014-03-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | SPANX-B polypeptides and their use |
GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
WO2014043518A1 (fr) | 2012-09-14 | 2014-03-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Protéine brachyury, vecteurs non levure, non poxvirus, codant pour la protéine brachyury, et leur utilisation |
KR20180057610A (ko) | 2015-08-03 | 2018-05-30 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 브라큐리 결실 돌연변이체, 브라큐리 결실 돌연변이체를 인코딩하는 비-효모 벡터, 및 이들의 용도 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2145092B (en) * | 1983-01-28 | 1988-04-07 | Univ New York | Protective peptide antigen |
AU584580B2 (en) * | 1982-09-08 | 1989-06-01 | Smith Kline - Rit | Hepatitis B virus vaccine |
ATE73349T1 (de) * | 1984-06-18 | 1992-03-15 | Chiron Corp | Hepatitisoberflaechenantigenpartikelvakzin. |
EP0171908A3 (fr) * | 1984-07-11 | 1987-07-15 | Takeda Chemical Industries, Ltd. | Antigène de surface du virus de l'hépatite B et production |
GB8421282D0 (en) * | 1984-08-22 | 1984-09-26 | Connaught Lab | Multispecific antigenic proteins |
EP0175261B1 (fr) * | 1984-09-12 | 1991-12-11 | Chiron Corporation | Immunogènes à base de particule hybride |
EP0180012A1 (fr) * | 1984-10-27 | 1986-05-07 | Wolfram H. Prof. Dr. Gerlich | Séquence de polypeptide immunogène du virus de l'hépatite B |
CN86100979A (zh) * | 1985-02-07 | 1986-12-17 | 史密丝克莱恩贝克曼公司 | 疟疾疫苗的制备方法 |
US4774175A (en) * | 1985-03-01 | 1988-09-27 | Centocor, Inc. | Immunochemical methods for the detection of antibody against HTLV-III |
US4683294A (en) * | 1985-04-03 | 1987-07-28 | Smith Kline Rit, S.A. | Process for the extraction and purification of proteins from culture media producing them |
EP0225887B1 (fr) * | 1985-04-08 | 1994-06-08 | Amgen Inc. | Procede et activeur hybride permettant de commander la transcription de genes exogenes |
FR2581394B1 (fr) * | 1985-05-02 | 1988-08-05 | Grp Genie Genetique | Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes |
US4816564A (en) * | 1986-01-31 | 1989-03-28 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
CA1310602C (fr) * | 1986-06-03 | 1992-11-24 | Hajime Horii | Promoteur de la levure et procede pour la preparation de proteines heterologues |
-
1988
- 1988-01-25 ZA ZA88488A patent/ZA88488B/xx unknown
- 1988-01-25 AP APAP/P/1988/000078A patent/AP56A/en active
- 1988-01-25 EP EP88870008A patent/EP0278940A3/fr not_active Withdrawn
- 1988-01-26 SU SU884355055A patent/SU1746887A3/ru active
- 1988-01-26 NZ NZ223297A patent/NZ223297A/en unknown
- 1988-01-26 IL IL85216A patent/IL85216A0/xx unknown
- 1988-01-27 PT PT86640A patent/PT86640B/pt not_active IP Right Cessation
- 1988-01-27 OA OA59269A patent/OA08801A/fr unknown
- 1988-01-28 AU AU10930/88A patent/AU1093088A/en not_active Abandoned
- 1988-01-28 DK DK043188A patent/DK43188A/da not_active Application Discontinuation
- 1988-01-29 DD DD88334296A patent/DD285612A5/de unknown
- 1988-01-29 MA MA21406A patent/MA21169A1/fr unknown
- 1988-01-29 HU HU88409A patent/HUT50876A/hu unknown
- 1988-01-29 DD DD88334294A patent/DD284899A5/de not_active IP Right Cessation
- 1988-01-29 NO NO880395A patent/NO880395L/no unknown
- 1988-01-29 DD DD88334295A patent/DD285994A5/de not_active IP Right Cessation
- 1988-01-29 YU YU00174/88A patent/YU17488A/xx unknown
- 1988-01-29 FI FI880428A patent/FI880428A/fi not_active IP Right Cessation
- 1988-01-29 JP JP63021137A patent/JPS6463382A/ja active Pending
- 1988-01-30 CN CN88100483A patent/CN1031395A/zh active Pending
- 1988-01-30 KR KR1019880000825A patent/KR880009130A/ko not_active Application Discontinuation
- 1988-02-03 TN TNTNSN88004A patent/TNSN88004A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
FI880428A (fi) | 1988-09-13 |
IL85216A0 (en) | 1988-07-31 |
DD285612A5 (de) | 1990-12-19 |
HUT50876A (en) | 1990-03-28 |
DK43188D0 (da) | 1988-01-28 |
ZA88488B (en) | 1988-10-26 |
AP56A (en) | 1989-09-26 |
KR880009130A (ko) | 1988-09-14 |
EP0278940A2 (fr) | 1988-08-17 |
NO880395D0 (no) | 1988-01-29 |
SU1746887A3 (ru) | 1992-07-07 |
JPS6463382A (en) | 1989-03-09 |
FI880428A0 (fi) | 1988-01-29 |
DD284899A5 (de) | 1990-11-28 |
DK43188A (da) | 1988-07-31 |
EP0278940A3 (fr) | 1988-12-07 |
TNSN88004A1 (fr) | 1990-07-10 |
PT86640A (pt) | 1988-02-01 |
OA08801A (fr) | 1989-03-31 |
AU1093088A (en) | 1988-08-04 |
CN1031395A (zh) | 1989-03-01 |
YU17488A (en) | 1991-02-28 |
NO880395L (no) | 1988-08-01 |
PT86640B (pt) | 1992-01-31 |
AP8800078A0 (en) | 1987-11-01 |
NZ223297A (en) | 1991-06-25 |
DD285994A5 (de) | 1991-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA21169A1 (fr) | Acides desoxyribonucleiques et procede de preparation des proteines qui en derivant. | |
MA22481A1 (fr) | Procede de preparation d'acides imidazolyl - alcenoiques . | |
DE3879209D1 (de) | Filtereinheiten fuer die vorbereitung von biologischen proben. | |
FR2576752B1 (fr) | Procede de purification de proteines du lait et de ses derives | |
DK110885D0 (da) | Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf | |
DE3875667D1 (de) | Menschliche papillomavirusnukleinsaeureproben. | |
FR2507183B1 (fr) | Procede de preparation d'acides 6,8-difluoro-1,4-dihydro-4-oxo-quinoleine-3-carboxyliques | |
ATE82835T1 (de) | Eiweissprodukt. | |
DE3772429D1 (de) | Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten. | |
IT8523408A0 (it) | Procedimento per la identificazione di acidi nucleici. | |
DE3854495D1 (de) | Tetrapyrrolaminocarbonsäuren. | |
OA08694A (fr) | Acides 3-pyrrolidinylthio-1-azabicyclo [3.2.0] -hept-2-ène-2-carboxyliques et procédés pour leur préparation. | |
PT88425A (pt) | Dna sequences recombinant dna molecules and processes for producing soluble t4 proteins | |
FI98830B (fi) | Menetelmä bifunktionaalisten proteiinien valmistamiseksi | |
MA21922A1 (fr) | Procede de purification d'acides aminomethylene-phosphoniques . | |
GR3015411T3 (en) | Methods of drying biological products. | |
NO884834D0 (no) | Disvovelanaloger av ll-e33288-antitumormidler. | |
PT87857A (pt) | Process for the preparation of novel immunossupressant peptides | |
NO905561D0 (no) | Proteiner og nukleinsyrer. | |
FR2630735B1 (fr) | Procede de preparations d'halogenophenols | |
FR2597981B1 (fr) | Procede de dosage des antigenes | |
DE3674535D1 (de) | Signalverarbeitungsmethode zur bestimmung des grundaufbaus von nukleinsaeuren. | |
DE68912536D1 (de) | Flüssiges Nahrungsmittel zur Proteinzuführung. | |
FR2561645B1 (fr) | Procede de preparation d'acides hydroxyalkylaminoacetiques | |
FR2611201B1 (fr) | Intermediaires de tetrazole et procede de preparation de derives antihypercholesterolemiques du tetrazole |